MedPath

The evaluation of treatment effect for age-related macular degeneration by using aflibercept preferentially in Yamaguchi University.

Not Applicable
Conditions
age-related macular degeneration
Registration Number
JPRN-UMIN000038335
Lead Sponsor
Department of Ophthalmology Yamaguchi University graduate school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
73
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patient who had a history of treatment using anti-VEGF agents, 2) The patient who entry to other intervention study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of visual acuity at 2nd year after starting treatment
Secondary Outcome Measures
NameTimeMethod
The treatment interval of aflibercept at 2nd year after starting treatment
© Copyright 2025. All Rights Reserved by MedPath